Brief Description
Evercrisp Biosciences is a biotechnology company engineering self-deliverable CRISPR genome editors intended to improve the area of oncology. The company focuses on the discovery and development of protein-based genome editors as therapeutics for multiple disease areas, enabling healthcare organizations to have novel enzymes with high cell permeability and editing efficiency.
Timeline
- 2021. Company founded.
Inventor
Jennifer Doudna